Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Simple CT metric predicts treatment-induced kidney impairment in prostate cancer patients
Though an effective treatment, Lu-177 radioligland therapy it is not without side effects, some of which can be severe.
FDA sued over ‘reckless and arbitrary’ semaglutide decision
The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.
Teleflex to acquire Biotronik’s vascular intervention business for $791M, split into 2 separate entities
The acquisition helps Teleflex expand its interventional and vascular portfolios. Biotronik, meanwhile, is shifting its focus toward implantable devices and digital healthcare.
Adaptable AI system detects subtle changes in imaging over time, has potential for multiple clinical settings
The Learning-based Inference of Longitudinal imAge Changes, or LILAC, system harnesses the power of machine learning to review medical images that have been collected over a prolonged period of time.
FDA clears Google smartwatch tech that calls 911 when a user’s heart stops
Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.

Early onset puberty ups risks of obesity later in life

Girls who enter puberty earlier have an increased risk of obesity as they get older, according to research published online Feb. 6 in the International Journal of Obesity.

Booze makes your heart race. Can it also trigger arrhythmias?

Higher alcohol consumption was linked to faster and faster heart rates in a study of more than 3,000 people attending the Munich Oktoberfest.

Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation

ABBOTT PARK, Ill., March 19, 2018 — Abbott today announced that the Ministry of Health Labour and Welfare (MHLW) in Japan granted national reimbursement for the company's MitraClip therapy to treat people with mitral regurgitation, a serious, progressive heart disease in which the mitral valve does not close properly, allowing blood to flow backward into the heart.

Canagliflozin linked to fewer deaths, heart failure hospitalizations for type 2 diabetics

Canagliflozin reduced the risk of death or hospitalization for heart failure by 22 percent among patients with type 2 diabetes and a high risk of cardiovascular disease, according to results of the CANVAS trial presented March 11 at the American College of Cardiology’s scientific session and published simultaneously in Circulation.

Air pollution may add to higher CVD risk in blacks

Increased exposure to air pollution may contribute to the higher risk of heart disease found in the black population, researchers reported in Arteriosclerosis, Thrombosis and Vascular Biology.

Mortality risk model combines EHR data, language processing to account for frailty

Applying natural language learning and deep neural networks to mortality risk models could help predict cardiovascular outcomes with more accuracy than modern support vector machines, researchers said at the 67th annual American College of Cardiology conference in Orlando.

TAVR: Who’s the wrong candidate?

Surgical risk is an outdated measure of a patient’s eligibility for aortic valve replacement procedures, one Norfolk, Virginia, cardiologist said at the American College of Cardiology’s annual symposium last weekend—clinicians should instead be turning their attention to the idea of “TAVR suitability.”

Clinical

Simple CT metric predicts treatment-induced kidney impairment in prostate cancer patients

FDA sued over ‘reckless and arbitrary’ semaglutide decision

Teleflex to acquire Biotronik’s vascular intervention business for $791M, split into 2 separate entities

Adaptable AI system detects subtle changes in imaging over time, has potential for multiple clinical settings

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops